CSI Market
Sign In | Register

Statera Biopharma Inc fka Cytocom Inc (STAB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access STAB Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Statera Biopharma Inc fka Cytocom Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent0.51
Short-term Investments, Total0.00
Cash & Short-term Investments0.00
Accounts receivable0.18
Other Current Assets0.43
Prepaid Expense, Current AS0.10
Total Current Assets1.21
Equipment/Property/Plant Net0.11
Goodwill net9.27
Intangible Assets1.24
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.01
Other Assets, Noncurrent0.91
Contract With Customer Asset Net Current0.18
Operating Lease Right Of Use Asset0.91
Restricted Cash Noncurrent0.00
Contract With Customer Asset Net Noncurrent0.00
Assets Noncurrent Continuing Operations11.53
Total Assets12.75
Liabilities
Accounts Payable and Accrued Liabilities, Current LI14.44
Notes Payable, Current NO6.40
Other Liabilities, Current1.39
Total Current Liabilities22.23
Long-term debt0.00
Total Long-term Debt0.00
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current0.39
Operating Lease Liability Noncurrent0.69
Liabilities Noncurrent Continuing Operation0.69
Total Liabilities22.92
Stockholders' Equity
Common Stock Value0.25
Additional Paid In Capital Common Stock133.53
Retained Earnings / Accumulated Deficit-144.08
Other Equity0.05
Common Stockholder's Equity-10.24
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.07
Total Stockholder's Equity-10.17
Liabilities & Stockholder's Equity12.75
4 historic quarters locked

Sign in to unlock the full Statera Biopharma Inc fka Cytocom Inc balance sheet history.

Sign In Create Free Account

About Statera Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-22-027371

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.